Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Building sensory axons: Delivery and distribution of NaV1.7 channels and effects of inflammatory mediators.

Akin EJ, Higerd GP, Mis MA, Tanaka BS, Adi T, Liu S, Dib-Hajj FB, Waxman SG, Dib-Hajj SD.

Sci Adv. 2019 Oct 23;5(10):eaax4755. doi: 10.1126/sciadv.aax4755. eCollection 2019 Oct.

2.

A Novel Gain-of-Function Nav1.9 Mutation in a Child With Episodic Pain.

Huang J, Estacion M, Zhao P, Dib-Hajj FB, Schulman B, Abicht A, Kurth I, Brockmann K, Waxman SG, Dib-Hajj SD.

Front Neurosci. 2019 Sep 3;13:918. doi: 10.3389/fnins.2019.00918. eCollection 2019.

3.

Resilience to Pain: A Peripheral Component Identified Using Induced Pluripotent Stem Cells and Dynamic Clamp.

Mis MA, Yang Y, Tanaka BS, Gomis-Perez C, Liu S, Dib-Hajj F, Adi T, Garcia-Milian R, Schulman BR, Dib-Hajj SD, Waxman SG.

J Neurosci. 2019 Jan 16;39(3):382-392. doi: 10.1523/JNEUROSCI.2433-18.2018. Epub 2018 Nov 20.

4.

The Novel Activity of Carbamazepine as an Activation Modulator Extends from NaV1.7 Mutations to the NaV1.8-S242T Mutant Channel from a Patient with Painful Diabetic Neuropathy.

Han C, Themistocleous AC, Estacion M, Dib-Hajj FB, Blesneac I, Macala L, Fratter C, Bennett DL, Waxman SG, Dib-Hajj SD.

Mol Pharmacol. 2018 Nov;94(5):1256-1269. doi: 10.1124/mol.118.113076. Epub 2018 Aug 22.

PMID:
30135145
5.

Conditional knockout of NaV1.6 in adult mice ameliorates neuropathic pain.

Chen L, Huang J, Zhao P, Persson AK, Dib-Hajj FB, Cheng X, Tan A, Waxman SG, Dib-Hajj SD.

Sci Rep. 2018 Mar 1;8(1):3845. doi: 10.1038/s41598-018-22216-w.

6.

A gain-of-function mutation in Nav1.6 in a case of trigeminal neuralgia.

Tanaka BS, Zhao P, Dib-Hajj FB, Morisset V, Tate S, Waxman SG, Dib-Hajj SD.

Mol Med. 2016 Sep;22:338-348. doi: 10.2119/molmed.2016.00131. Epub 2016 Aug 3.

7.

Multistate structural modeling and voltage-clamp analysis of epilepsy/autism mutation Kv10.2-R327H demonstrate the role of this residue in stabilizing the channel closed state.

Yang Y, Vasylyev DV, Dib-Hajj F, Veeramah KR, Hammer MF, Dib-Hajj SD, Waxman SG.

J Neurosci. 2013 Oct 16;33(42):16586-93. doi: 10.1523/JNEUROSCI.2307-13.2013.

8.

Discovery of Dap-3 polymyxin analogues for the treatment of multidrug-resistant Gram-negative nosocomial infections.

Magee TV, Brown MF, Starr JT, Ackley DC, Abramite JA, Aubrecht J, Butler A, Crandon JL, Dib-Hajj F, Flanagan ME, Granskog K, Hardink JR, Huband MD, Irvine R, Kuhn M, Leach KL, Li B, Lin J, Luke DR, MacVane SH, Miller AA, McCurdy S, McKim JM Jr, Nicolau DP, Nguyen TT, Noe MC, O'Donnell JP, Seibel SB, Shen Y, Stepan AF, Tomaras AP, Wilga PC, Zhang L, Xu J, Chen JM.

J Med Chem. 2013 Jun 27;56(12):5079-93. doi: 10.1021/jm400416u. Epub 2013 Jun 18.

PMID:
23735048
9.

Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital.

Gootz TD, Lescoe MK, Dib-Hajj F, Dougherty BA, He W, Della-Latta P, Huard RC.

Antimicrob Agents Chemother. 2009 May;53(5):1998-2004. doi: 10.1128/AAC.01355-08. Epub 2009 Mar 2.

10.

Bacterial efflux pump inhibitors.

Kamicker BJ, Sweeney MT, Kaczmarek F, Dib-Hajj F, Shang W, Crimin K, Duignan J, Gootz TD.

Methods Mol Med. 2008;142:187-204. doi: 10.1007/978-1-59745-246-5_15.

PMID:
18437315
11.

Enterococcal virulence determinants may be involved in resistance to clinical therapy.

Marra A, Dib-Hajj F, Lamb L, Kaczmarek F, Shang W, Beckius G, Milici AJ, Medina I, Gootz TD.

Diagn Microbiol Infect Dis. 2007 May;58(1):59-65. Epub 2007 Feb 14.

PMID:
17300898
13.

Genetic and molecular characterization of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae with unusually high resistance to ampicillin.

Kaczmarek FS, Gootz TD, Dib-Hajj F, Shang W, Hallowell S, Cronan M.

Antimicrob Agents Chemother. 2004 May;48(5):1630-9.

14.

CJ-21,058, a new SecA inhibitor isolated from a fungus.

Sugie Y, Inagaki S, Kato Y, Nishida H, Pang CH, Saito T, Sakemi S, Dib-Hajj F, Mueller JP, Sutcliffe J, Kojima Y.

J Antibiot (Tokyo). 2002 Jan;55(1):25-9.

15.

Characterization of the dual start motif of a class II holin gene.

Barenboim M, Chang CY, dib Hajj F, Young R.

Mol Microbiol. 1999 May;32(4):715-27.

16.

Cloning and characterization of a novel macrolide efflux gene, mreA, from Streptococcus agalactiae.

Clancy J, Dib-Hajj F, Petitpas JW, Yuan W.

Antimicrob Agents Chemother. 1997 Dec;41(12):2719-23.

17.

mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae.

Tait-Kamradt A, Clancy J, Cronan M, Dib-Hajj F, Wondrack L, Yuan W, Sutcliffe J.

Antimicrob Agents Chemother. 1997 Oct;41(10):2251-5.

18.

Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes.

Clancy J, Petitpas J, Dib-Hajj F, Yuan W, Cronan M, Kamath AV, Bergeron J, Retsema JA.

Mol Microbiol. 1996 Dec;22(5):867-79.

PMID:
8971709
19.

Supplemental Content

Loading ...
Support Center